People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RayzeBio, Inc. | — | Biotechnology | Series D+ | $396.4M | $3.4B | 2022 |
| Gyroscope Therapeutics Ltd | — | Biotechnology | Series D+ | $148.0M | $4.8B | 2021 |
| Star Therapeutics LLC | — | Pharma | Series D+ | $125.0M | $935.3M | 2025 |
| Quanta Therapeutics, Inc. | — | Biotechnology | Series C | $120.8M | $698.7M | 2021 |
| Vera Therapeutics, Inc. | — | Biotechnology | Series C | $70.7M | $2.6B | 2020 |
| Marea Therapeutics, Inc. | — | Biotechnology | Series C | $65.4M | $595.3M | 2024 |
Maha Katabi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Maha Katabi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Beth Seidenberg | 2 | 15 |
| Aaron Royston | 2 | 7 |
| Carl Gordon | 1 | 24 |
| Jerel Davis | 1 | 13 |
| Patrick Enright | 1 | 10 |
| Chris Garabedian | 1 | 8 |
| Kurt Von Emster | 1 | 6 |
| SCOTT MORRISON | 1 | 6 |
| Jason Hafler | 1 | 6 |
| Aaron Kantoff | 1 | 6 |
| Nancy Stagliano | 1 | 5 |
| Arjun Goyal | 1 | 5 |
| Ian Clark | 1 | 5 |
| Matthew Fust | 1 | 4 |
| Samuel Saks | 1 | 3 |
| Mary Tagliaferri | 1 | 3 |
| Scott Robertson | 1 | 3 |
| Maria Fardis | 1 | 3 |
| Michelle Carpenter | 1 | 2 |
| Ted Love | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.